ROS EO. The US FDA-Approved Drug Dimethyl Fumarate, an Nrf2 Activator, for Treating Multiple Sclerosis: The Mechanisms of Action Revisited. React Oxyg Species (Apex) [Internet]. 2021Feb.23 [cited 2025Mar.27];11:n7–n8. Available from: https://rosj.org/index.php/ros/article/view/286